Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Celyad SA ADR
CYAD
$
7.29
28%
Fri March 26th, 2021
06:52
Earnings
Analysis
Celyad Oncology's (CYAD) CEO Filippo Petti on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha
Fri March 12th, 2021
19:40
Analysis
Celyad Oncology (CYAD) Investor Presentation - Slideshow
Seeking Alpha
Thu January 14th, 2021
22:25
Analysis
Celyad Oncology: Chance To Get In Early And Cheap
Seeking Alpha
Tue December 22nd, 2020
22:15
IPO
Analysis
Gracell Biotechnologies Starts IPO Effort
Seeking Alpha
Tue September 29th, 2020
21:53
Analysis
Celyad-Merck Team Up to Evaluate CYAD-101 in Colorectal Cancer
Zacks
Sat August 8th, 2020
14:07
Earnings
Analysis
Celyad Oncology's (CYAD) CEO Filippo Petti on First Half 2020 Results - Earnings Call Transcript
Seeking Alpha
Sun July 5th, 2020
16:05
IPO
Analysis
IPO Update: Nkarta Proposes Terms For $150 Million IPO
Seeking Alpha
Fri June 5th, 2020
06:55
Analysis
Celyad's Positive Data And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Sat May 23rd, 2020
12:43
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Stocks To Watch: Spotlight On SpaceX, Costco, ASCO And HBO Max
Seeking Alpha
